Long-term Real-world Protection Afforded by Third mRNA Doses Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections, Coronavirus Disease 19-related Emergency Attendances and Hospitalizations Amongst Older Singaporeans During an Omicron XBB Wave

Liang En Wee(Agency for Science, Technology and Research), Kelvin Bryan Tan(Agency for Science, Technology and Research), Calvin J. Chiew(Ministry of Health), David Chien Lye(National University of Singapore), Ben Ong(Ministry of Health), Deanette Pang(Ministry of Health), Janice Ser Huey Tan(Ministry of Health), Vernon Lee(Ministry of Health)
Clinical Infectious Diseases
June 6, 2023
10.1093/cid/ciad345
Cited by 37

Related Papers

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance
|JAMA|2018|761
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Setting-specific Transmission Rates: A Systematic Review and Meta-analysis
|Clinical Infectious Diseases|2021|241
Metagenome-wide association analysis identifies microbial determinants of post-antibiotic ecological recovery in the gut
|Nature Ecology & Evolution|2020|178
Unintended consequences of infection prevention and control measures during COVID-19 pandemic
|American Journal of Infection Control|2020|171
Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study
|Clinical Infectious Diseases|2020|155